CT SB00262 | 2021 | General Assembly

Status

Spectrum: Bipartisan Bill
Status: Engrossed on May 26 2021 - 50% progression, died in chamber
Action: 2021-05-27 - House Calendar Number 554
Text: Latest bill text (Comm Sub) [PDF]

Summary

To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act Requiring Manufacturers Of Brand Name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

Sponsors


Roll Calls

2021-05-26 - Senate - Senate Roll Call Vote 261 (Y: 23 N: 11 NV: 2 Abs: 0) [PASS]
2021-05-17 - Joint - APP Vote Tally Sheet (Joint Favorable) (Y: 33 N: 16 NV: 0 Abs: 2) [PASS]
2021-05-03 - Joint - JUD Vote Tally Sheet-A (Y: 13 N: 20 NV: 0 Abs: 6) [FAIL]
2021-05-03 - Joint - JUD Vote Tally Sheet (Joint Favorable) (Y: 25 N: 13 NV: 0 Abs: 1) [PASS]
2021-02-16 - Joint - GL Vote Tally Sheet (Joint Favorable) (Y: 16 N: 3 NV: 0 Abs: 1) [PASS]

History

DateChamberAction
2021-05-27SenateHouse Calendar Number 554
2021-05-27SenateFavorable Report, Tabled for the Calendar, House
2021-05-26SenateSenate Passed
2021-05-18SenateFavorable Report, Tabled for the Calendar, Senate
2021-05-18SenateNo New File by Committee on Appropriations
2021-05-18SenateReported Out of Legislative Commissioners' Office
2021-05-18SenateFiled with Legislative Commissioners' Office
2021-05-17SenateJoint Favorable
2021-05-12SenateReferred by Senate to Committee on Appropriations
2021-05-04SenateFavorable Report, Tabled for the Calendar, Senate
2021-05-04SenateNo New File by Committee on Judiciary
2021-05-04SenateReported Out of Legislative Commissioners' Office
2021-05-04SenateFiled with Legislative Commissioners' Office
2021-05-03SenateJoint Favorable
2021-04-28SenateReferred by Senate to Committee on Judiciary
2021-03-04SenateFile Number 12
2021-03-04SenateSenate Calendar Number 48
2021-03-04SenateFavorable Report, Tabled for the Calendar, Senate
2021-03-04SenateReported Out of Legislative Commissioners' Office
2021-02-26SenateReferred to Office of Legislative Research and Office of Fiscal Analysis 03/03/21 5:00 PM
2021-02-17SenateFiled with Legislative Commissioners' Office
2021-02-16SenateJoint Favorable
2021-01-25SenatePublic Hearing 01/28
2021-01-22SenateReferred to Joint Committee on General Law

Connecticut State Sources

TypeSource
Summaryhttps://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00262&which_year=2021
Texthttps://www.cga.ct.gov/2021/TOB/S/PDF/2021SB-00262-R00-SB.PDF
Texthttps://www.cga.ct.gov/2021/TOB/S/PDF/2021SB-00262-R01-SB.PDF
Texthttps://www.cga.ct.gov/2021/TOB/S/PDF/2021SB-00262-R02-SB.PDF
Texthttps://www.cga.ct.gov/2021/TOB/S/PDF/2021SB-00262-R03-SB.PDF
Amendmenthttps://www.cga.ct.gov/2021/lcoamd/pdf/2021LCO09650-R00-AMD.pdf
Supplementhttps://www.cga.ct.gov/2021/FN/PDF/2021SB-00262-R000012-FN.PDF
Supplementhttps://www.cga.ct.gov/2021/BA/PDF/2021SB-00262-R000012-BA.PDF
Supplementhttps://www.cga.ct.gov/2021/fna/pdf/2021SB-00262-R00LCO09650-FNA.PDF
Roll Callhttps://www.cga.ct.gov/2021/TS/S/PDF/2021SB-00262-R00GL-CV42-TS.PDF
Roll Callhttps://www.cga.ct.gov/2021/TS/S/PDF/2021SB-00262-R00JUD-CV159-TS.PDF
Roll Callhttps://www.cga.ct.gov/2021/TS/S/PDF/2021SB-00262-R00JUDA-CV160-TS.PDF
Roll Callhttps://www.cga.ct.gov/2021/TS/S/PDF/2021SB-00262-R00APP-CV116-TS.PDF
Roll Callhttps://www.cga.ct.gov/2021/VOTE/S/PDF/2021SV-00261-R00SB00262-SV.PDF

Bill Comments

feedback